Journal of Radiopharmaceuticals and Molecular Probes (대한방사성의약품학회지)

Korean Society of Radiopharmaceuticals and Molecular Probes (대한방사성의약품학회)
권호 표지
DOI QR코드

DOI QR Code

Radio-Iodinated arbutin for tumor imaging

  • Huynh, Phuong Tu (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) ;
  • Ha, Yeong Su (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) ;
  • Lee, Woonghee (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University) ;
  • Yoo, Jeongsoo (Department of Molecular Medicine, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University)
  • Received : 2017.12.08
  • Accepted : 2017.12.22
  • Published : 2017.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Arbutin is a hydroquinone derivative with a glucose moiety. As a tyrosinase inhibitor, it is widely used as a skin-whitening cosmetic agent for the treatment of cutaneous hyperpigmentary disorders, such as melasma and freckles. In the medical field, many studies have addressed the use of arbutin in various tumors, but the mechanism for tumor uptake of arbutin is still unclear. In this paper, we radiolabeled arbutin using radioiodine and studied its pharmacokinetics and tumor uptake via biodistribution experiments and single-photon emission computed tomography (SPECT) imaging. Radiolabeled $^{131}I-arbutin$ was stable for up to 24 h in PBS and serum. Biodistribution studies and SPECT imaging indicated high uptake of the compound in the bladder and kidneys shortly after injection. Twenty-four hours post-injection, significant deiodination was observed. Apart from high thyroid uptake, selective tumor uptake was clearly observed. The tumor-to-muscle and tumor-to-blood ratios were 26 and 9, respectively.

Keywords

References

  1. Kubo I, Ying BP. Phenolic constituents of California buckeye fruit. Phytochemistry 1992;31:3793-3794. https://doi.org/10.1016/S0031-9422(00)97529-0
  2. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 1996;276:765-769.
  3. Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Kurik T. Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model, Biol Pharm Bull 2004;27:510-514. https://doi.org/10.1248/bpb.27.510
  4. Solano F, Briganti S, Picardo M, Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 2006;19:550-571. https://doi.org/10.1111/j.1600-0749.2006.00334.x
  5. Ertam I, Mutlu B, Unal I, Alper S, Kivcak B, Ozer O. Efficiency of ellagic acid and arbutin in melisma: a randomized, prospective, open-label study. J Dermatol 2008;35:570-574. https://doi.org/10.1111/j.1346-8138.2008.00522.x
  6. Lin JW, Chiang HM, Lin YC, Wen KC. Natural Products with Skin - Whitening Effects. J Food Drug Anal 2008;16:1-10.
  7. Ebanks JP, Wickett RR, Boissy RE. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci 2009;10:4066-4087. https://doi.org/10.3390/ijms10094066
  8. Chakraborty AK, Funasaka Y, Komoto M, Ichihashi M. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res 1998;11: 206-212. https://doi.org/10.1111/j.1600-0749.1998.tb00731.x
  9. Cheng SL, Liu RH, Sheu JN, Chen ST, Sinchaikul S, Tsay GJ. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. J Biomed Sci 2007;14:87-105. https://doi.org/10.1007/s11373-006-9130-6
  10. Li H, Jeong YM, Kim SY, Kim MK, Kim DS. Arbutin inhibits TCCSUP human bladder cancer cell proliferation via up-regulation of p21. Pharmazie 2011;66:306-309.
  11. Nawarak J, Huang-Liu R, Kao SH, Liao HH, Sinchaikul S, Chen ST, Cheng SL. Proteomics analysis of A375 human malignant melanoma cells in response to arbutin treatment. Biochim Biophys Acta 2009;1794:159-167. https://doi.org/10.1016/j.bbapap.2008.09.023
  12. Ye X, Sun Y, Xu Y, Chen Z, Lu S. Integrated in Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) inhibitors. Med Chem 2016;12:613-620. https://doi.org/10.2174/1573406412666160307151535
  13. Warburg O, Wind F, Negelein E. THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 1927;8:519-530. https://doi.org/10.1085/jgp.8.6.519
  14. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674. https://doi.org/10.1016/j.cell.2011.02.013
  15. Calvaresia EC, Hergenrother PJ. Glucose conjugation for the specific targeting and treatment of cancer. Chem Sci 2013;4: 2319-2333. https://doi.org/10.1039/c3sc22205e
  16. Seevers RH, Counsell RE. Radioiodination techniques for small organic molecules. Chem Rev 1982;82:575-590. https://doi.org/10.1021/cr00052a002
  17. Thongchai W, Liawruangrath B, Liawruangrath S. Highperformance liquid chromatographic determination of arbutin in skin-whitening creams and medicinal plant extracts. J Cosmet Sci 2007;58:35-44.
  18. Gallo FR, Pagliuca G, Multari G, Panzini G, D'amore E, Altieri I. New High-performance Liquid Chromatography- DAD Method for Analytical Determination of Arbutin and Hydroquinone in Rat Plasma, Indian J Pharm Sci 2015;77:530-535. https://doi.org/10.4103/0250-474X.169031
  19. Dong M, Li G, Li J, Zhou F, Gong Y, Zhang X, Zhao N. Immunological detection of arbutin, Tsinghua Sci Technol 1999; 4:1509-1514.